Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Why Jermaine Dupri Is Suing Sony Music For $18 Million

    July 7, 2026

    Swiss president arrives in Mexico for official visit

    July 7, 2026

    Start vs. Sit: 2 must-plays and who to avoid in Week 6

    July 7, 2026
    Facebook X (Twitter) Instagram
    Select Language
    Facebook X (Twitter) Instagram
    NEWS ON CLICK
    Subscribe
    Tuesday, July 7
    • Home
      • United States
      • Canada
      • Spain
      • Mexico
    • Top Countries
      • Canada
      • Mexico
      • Spain
      • United States
    • Politics
    • Business
    • Entertainment
    • Fashion
    • Health
    • Science
    • Sports
    • Travel
    NEWS ON CLICK
    Home»Health & Fitness»US Health & Fitness»The Truth About Testosterone in Women: What Medicine Has Overlooked
    US Health & Fitness

    The Truth About Testosterone in Women: What Medicine Has Overlooked

    News DeskBy News DeskJuly 7, 2026No Comments7 Mins Read
    Share Facebook Twitter Pinterest Copy Link LinkedIn Tumblr Email VKontakte Telegram
    The Truth About Testosterone in Women: What Medicine Has Overlooked
    Share
    Facebook Twitter Pinterest Email Copy Link

    For decades, women’s hormone health has been centered around one conversation: estrogen.

    Meanwhile, testosterone has either been ignored completely or treated like something women should fear, despite the fact that it plays a critical role in female physiology, metabolism, cognition, muscle preservation, resilience, and vitality.

    And honestly? Medicine has failed women in this conversation. I often call this the blind spot of women’s health. Traditional medicine doesn’t acknowledge that testosterone is needed in the female population, especially as they get older. 

    Because testosterone is not just a “male hormone.” Women need it too. And pretending otherwise has left countless women struggling through midlife while being told everything looks “normal.”

    I see this constantly in practice. Women come in exhausted, foggy, unmotivated, struggling to recover from workouts, watching their body composition change despite doing “everything right,” and wondering why they suddenly feel disconnected from themselves.

    And many of them have already been told: “Your labs are normal.” “You’re just stressed.” “That’s part of aging.” But normal lab results do not always mean normal function.

    One of the biggest patterns in midlife women is that they know something is wrong long before traditional medicine recognizes it. They feel the shift physically, mentally, and emotionally, but because they are still technically “within range,” they are often dismissed instead of properly evaluated. 

    This is a problem because by the time many women finally receive answers, their function has already declined significantly.

    Testosterone matters in women

    Women naturally produce testosterone throughout their lives. In fact, testosterone production peaks in early adulthood and gradually declines with age, often significantly during perimenopause and menopause.

    Yet most hormone conversations still focus almost entirely on estrogen and progesterone. That is a massive blind spot. Because testosterone influences energy and motivation, lean muscle mass, strength and recovery, bone density, cognitive performance, mood resilience, libido and sexual function, metabolic health, and body composition.

    This is foundational female physiology. And women often notice the effects long before medicine acknowledges them.

    Clinicians hear this every single week: “I just don’t feel like myself anymore.”

    Not because women suddenly become lazy, unmotivated, or emotionally unstable in midlife, but because major physiologic changes are happening underneath the surface.

    The problem is that healthcare has normalized dysfunction for so long that many women think suffering through midlife is simply expected. It is not.

    Perimenopause is more than a reproductive transition

    Perimenopause is often misunderstood as a short phase before menopause. In reality, it can begin 7–10 years before a woman’s final menstrual cycle.

    And it is not just a reproductive transition. It is also a metabolic and neurologic transition.

    This is when many women begin experiencing brain fog, sleep disruption, anxiety, weight resistance, loss of muscle tone, reduced stress tolerance, mood changes, fatigue, and low libido.

    Women often say, “I feel like I lost my edge.” And honestly, that statement says a lot.

    Because many of these women are still working, raising families, exercising, eating well, and functioning at a high level externally, while feeling completely different internally.

    But instead of looking deeper, many women are told, “You just need better stress management.” “You need to exercise more.” “That’s just what happens in your 40s.”

    Meanwhile, they are experiencing real hormone fluctuations, including insulin sensitivity, inflammation, neurotransmitter balance, muscle preservation, hormone signaling, and metabolic resilience. This is not simply “getting older.” This is physiology. And women deserve practitioners who understand that.

    The problem is not just hormones, it’s how we interpret them

    One of the biggest failures in women’s hormone care is that symptoms are still being evaluated through outdated reference ranges instead of clinical context.

    Most conventional lab ranges were designed to identify disease, not optimize function. There is a difference. A woman can technically fall “within range” while still experiencing clear symptoms of hormonal decline.

    I see this constantly. Women are carrying years of symptoms while being told everything looks “fine” on paper. Meanwhile, nobody has explained free testosterone, SHBG, tissue-level hormone signaling, why symptoms matter, and why “normal” does not always equal optimal.

    Testosterone is especially difficult because female reference ranges are broad, testing methods are inconsistent, free testosterone is often overlooked because of working with decimals, and hormone availability matters just as much as total levels.

    And this is where many women get missed.

    The reality is that women are often being evaluated through a disease-management lens instead of a functional health lens. There is a massive difference between preventing disease and preserving vitality.

    Hormones do not work in isolation

    One of the biggest mistakes in hormone medicine is oversimplifying physiology into “high” versus “low.” Hormones function inside an interconnected system. You cannot evaluate testosterone without considering insulin resistance, sleep quality, cortisol patterns, inflammation, thyroid function, body composition, and metabolic health.

    Two women can have similar hormone levels and experience completely different symptoms depending on the environment in which those hormones are functioning within.

    This is why cookie-cutter hormone medicine fails so many women. And this is why individualized medicine matters. Because symptoms matter. Function matters. Context matters.

    The fear around testosterone lacks nuance

    Many women hear the word testosterone and naturally think of things like masculinization, hair loss, aggression, and male hormones. But that oversimplifies physiology entirely.

    Women already produce testosterone naturally. The conversation should not be whether women should have testosterone therapy. The real conversation should be:

    • Is therapy appropriate?
    • Is it individualized?
    • Is it monitored correctly?
    • Is the provider evaluating the full physiologic picture?

    Because hormones are powerful, nuanced, and heavily influenced by context. This is where education matters. This is where clinical reasoning matters. And this is where women deserve far better conversations than fear-based oversimplifications.

    Midlife women are being under-treated

    One of the most concerning patterns I see in healthcare is how quickly women’s symptoms are minimized during perimenopause and menopause. Loss of vitality becomes normalized. Muscle loss becomes “aging.” Fatigue becomes burnout.  Weight resistance becomes “eat less and exercise more.”

    Meanwhile, women are experiencing measurable physiologic changes that directly impact long-term health outcomes. And under-treatment has consequences. Untreated hormonal decline can contribute to loss of lean muscle mass, reduced bone density, increased visceral fat, poor metabolic resilience, worsening insulin resistance, cognitive decline, and reduced quality of life.

    This matters because longevity is not just about lifespan. It is about maintaining strength, cognition, independence, function, resilience, and vitality. Women deserve more than simply surviving midlife. They deserve to feel strong through it.

    Better hormone conversations are needed

    The future of women’s healthcare cannot continue to be built on symptom dismissal, outdated frameworks, and reactive medicine. Women deserve evidence-based conversations, better education, physiology-based care, individualized evaluation, and providers who understand functional decline before disease develops.

    This does not mean every woman needs testosterone therapy. It means women deserve proper evaluation that considers symptoms, metabolic health, body composition, sleep, inflammation, lifestyle, hormone signaling, and long-term health outcomes.

    Because the goal is not simply “normal labs.” The goals are vitality, resilience, and helping women maintain long-term strength, cognition, confidence, and quality of life.

    We have normalized dysfunction for so long that many women think suffering is expected. It is not. And women deserve far better than being told they are “fine” while their vitality disappears.

    Photo: Drazen Zigic, Getty Images


    Lexi Yoo, NP, is a double board-certified nurse practitioner and the founder of Yoo Direct Health and YDH Training Academy. Women’s hormone expert, national keynote speaker, and host of The Better Yoo Project Podcast, Lexi is a longevity medicine expert, practitioner mentor, and education-first disruptor challenging outdated standards in midlife and metabolic care to advance a systems-based approach to hormone health, metabolism, and modern longevity care.

    This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.

    Barriers to health Equity hormone health menopause perimenopause testosterone women's health
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Telegram Copy Link
    News Desk
    • Website

    News Desk is the dedicated editorial force behind News On Click. Comprised of experienced journalists, writers, and editors, our team is united by a shared passion for delivering high-quality, credible news to a global audience.

    Related Posts

    US Health & Fitness

    The AI Use Case That Healthcare is Overlooking

    July 7, 2026
    US Health & Fitness

    The Foundation Is Built — Now We Must Secure the Future of Interoperability

    July 7, 2026
    US Health & Fitness

    Life Not As We Know It – The Health Care Blog

    July 7, 2026
    US Health & Fitness

    Report Highlights Private Equity’s Lesser-Known Strategy: Nonprofit Joint Ventures

    July 6, 2026
    US Health & Fitness

    Why Penn Medicine Is Deploying AI Agents for Patient Intake

    July 6, 2026
    US Health & Fitness

    A $1B Acquisition Gives Novartis a Way to Stand Out in Crowded Area of Cancer

    July 6, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Don't Miss

    Why Jermaine Dupri Is Suing Sony Music For $18 Million

    News DeskJuly 7, 20260

    Hip-hop legend Jermaine Dupri is taking Sony Music Entertainment to court, alleging that the music…

    Swiss president arrives in Mexico for official visit

    July 7, 2026

    Start vs. Sit: 2 must-plays and who to avoid in Week 6

    July 7, 2026

    Mets Designate Guillo Zuñiga For Assignment

    July 7, 2026
    Tech news by Newsonclick.com
    Top Posts

    How sick is sick enough? New Medicaid work rule worries patient advocates, states

    June 7, 2026

    Why Jermaine Dupri Is Suing Sony Music For $18 Million

    July 7, 2026

    ‘DWTS’ Val Chmerkovskiy Talks Being Ciara Miller’s Top Choice

    June 7, 2026

    Harry Styles Teases ‘Together, Together’ With an Amsterdam and Ten Hint

    June 7, 2026
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    Editors Picks

    Why Jermaine Dupri Is Suing Sony Music For $18 Million

    July 7, 2026

    Swiss president arrives in Mexico for official visit

    July 7, 2026

    Start vs. Sit: 2 must-plays and who to avoid in Week 6

    July 7, 2026

    Mets Designate Guillo Zuñiga For Assignment

    July 7, 2026
    About Us

    NewsOnClick.com is your reliable source for timely and accurate news. We are committed to delivering unbiased reporting across politics, sports, entertainment, technology, and more. Our mission is to keep you informed with credible, fact-checked content you can trust.

    We're social. Connect with us:

    Facebook X (Twitter) Instagram Pinterest YouTube
    Latest Posts

    Why Jermaine Dupri Is Suing Sony Music For $18 Million

    July 7, 2026

    Swiss president arrives in Mexico for official visit

    July 7, 2026

    Start vs. Sit: 2 must-plays and who to avoid in Week 6

    July 7, 2026

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    Facebook X (Twitter) Instagram Pinterest
    • About Us
    • Editorial Policy
    • Privacy Policy
    • Terms and Conditions
    • Disclaimer
    • Advertise
    • Contact Us
    © 2026 Newsonclick.com || Designed & Powered by ❤️ Trustmomentum.com.

    Type above and press Enter to search. Press Esc to cancel.